Gastroparesis pathophysiology

Revision as of 20:28, 26 January 2018 by Madhu Sigdel (talk | contribs)
Jump to navigation Jump to search

Gastroparesis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gastroparesis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastroparesis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastroparesis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastroparesis pathophysiology

CDC on Gastroparesis pathophysiology

Gastroparesis pathophysiology in the news

Blogs on Gastroparesis pathophysiology

Directions to Hospitals Treating Gastroparesis

Risk calculators and risk factors for Gastroparesis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]

Overview

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].

OR

[Pathogen name] is usually transmitted via the [transmission route] route to the human host.

OR

Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.

OR


[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].

OR

The progression to [disease name] usually involves the [molecular pathway].

OR

The pathophysiology of [disease/malignancy] depends on the histological subtype.

Pathophysiology

Pathogenesis

  • The exact pathogenesis of gastroparesis is not fully understood. However, it is well known that gastric emptying process is the result of interaction of smooth muscles, extrinsic and enteric autonomic nervous system, and interstitial cells of Cajal.[1] The final process for delay of gastric emptying is increased tone of pylorus. Gastric emptying is mediated by the vagus nerve, which involves fundus accommodation, antrum contraction, and pyloric relaxation. Interstitial cells of Cajal are the pacemaker cells in the gut with unique ability to generate and propagate slow waves in gastrointestinal muscles. The electrical slow wave activity is the determinant of the characteristic frequency of phasic contractions of the stomach, intestine and colon as well as the direction and velocity of propagation of peristaltic activity, in coordination with the enteric nervous system.[2] Interstitial cells of Cajal regulate both gastric pacemaker activity and enteric neurons, which initiate smooth muscle cell activity.[3] slow wave activity originated from a pacemaker region at the mid/upper corpus on the greater curvature. From this pacemaker region, a band of activity rapidly formed and propagated in an organised fashion towards the distal antrum.[4]

OR

  • It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
  • [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
  • Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
  • [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
  • The progression to [disease name] usually involves the [molecular pathway].
  • The pathophysiology of [disease/malignancy] depends on the histological subtype.

Genetics

  • [Disease name] is transmitted in [mode of genetic transmission] pattern.
  • Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
  • The development of [disease name] is the result of multiple genetic mutations.

Associated Conditions

Gross Pathology

  • On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Microscopic Pathology

  • On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

References

  1. Oh JH, Pasricha PJ (2013). "Recent advances in the pathophysiology and treatment of gastroparesis". J Neurogastroenterol Motil. 19 (1): 18–24. doi:10.5056/jnm.2013.19.1.18. PMC 3548121. PMID 23350043.
  2. Camborová P, Hubka P, Sulková I, Hulín I (2003). "The pacemaker activity of interstitial cells of Cajal and gastric electrical activity". Physiol Res. 52 (3): 275–84. PMID 12790758.
  3. Parkman HP (2015). "Idiopathic gastroparesis". Gastroenterol Clin North Am. 44 (1): 59–68. doi:10.1016/j.gtc.2014.11.015. PMC 4324534. PMID 25667023.
  4. Cheng LK (2015). "Slow wave conduction patterns in the stomach: from Waller's foundations to current challenges". Acta Physiol (Oxf). 213 (2): 384–93. doi:10.1111/apha.12406. PMC 4405773. PMID 25313679.

Template:WH Template:WS